Details
Category: Volume 05 Issue 07 July 2017
Hits: 1329

Title: Hepatic Transaminases Early Indicator of Dengue Fever Study Conducted In Rural Population of Northen India

Authors: Sushil Kumar, Ranjit Kumar Nim, Rajesh Kumar, Dheeraj Kela

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i7.224

Abstract

Aim of the study: Measurement of S.SGOT and SGPT and its use as a early indicator of Dengue Fever.

Material and Method: Study conducted in rural population of central India. 120 Positive cases of dengue fever was included in study out of which 72 male and 48 female patients.

The serum glutamic oxaloacetic transaminases (SGOT) and serum glutamic pyruvic transaminases (SGPT) were estimated by enzyme kinetic method by adding 100μl of patient’s serum with 1000μl of reagent and the concentration was read immediately in semi-automated analyser at340nm wavelength with 1cm optical path at 37oC temperature for 120 dengue positive cases.

Results: The serum glutamic pyruvic transaminases (SGPT) levels were found to be elevated more in females when compared with males. The serum glutamic oxaloacetic transaminases (SGOT) levels were also found to be higher in females. Overall, 70% of dengue fever cases of this study showed increased values of both SGOT and SGPT. SGOT was increased more compared to SGPT.

Conclusion: This study showed increased values of serum transaminases (SGOT&SGPT) reflects hepatic parenchymal demage and its rising level can be use as early indicator of Dengue Fever.

Keywords: Dengue fever, serum glutamic pyruvic transaminases, serum glutamic oxaloacetic transaminases, hepatic injury.

References

  1. Gubler D. J. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998;11(3): 480–496.
  2. Rigau-Pérez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998;352: 971–977.
  3. Park 23rdedition ,246-47
  4. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, N.Kunentrasai et al. Early clinical and laboratory indicators of acute dengue J  Infect Dis.1997;176:313–321.
  5. Organización Panamericana de la Salud. Definiciones de casos. Dengue. Boletín Epidemiológico. 2000;21:14–15.
  6. Rigau-Perez JG, Bonilla GL. An evaluation of modified case definitions for the detection of dengue hemorrhagic fever. Puerto Rico Association  of Epidemio-logists. P R Health Sci J. 1999;18:347352.
  7. Zhang JL, Wang JL, Gao N, Chen ZT, Tian YP, An Up-regulated expression of beta3 integrin  induced by dengue virus serotype 2 infection  associated with virus entry into human dermal microvascular endothelial cells. Biochem Biophys Res Commun. 2007 May 11. 356(3):763-768.
  8. Halstead SB, Heinz FX, Barrett AD, Roehrig JT. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria.Vaccine.2005 Jan 4.23(7):849-856.
  9. Limjindaporn T, Wongwiwat W, Noisakran S, Srisawat C, Netsawang J, Puttikhunt C, et al. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.Biochem Biophys Res Commun.2009 Feb 6. 379(2):196-200.
  10. Imported dengue--United States, 1997 and 1998.MMWR Morb Mortal Wkly Rep. 2000 Mar 31. 49(12):248-253.
  11. Govt of India,Annual Report 2012 2012,DGHS,Ministry of health and Family  Welfare,New Delhi
  12. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F. Spectrum of disease and relation to place of exposure among ill returned travelers.N Engl J Med. 2006 Jan 12. 354(2):119-130.
  13. Kyle JL, Harris E. Global spread and persistence of dengue.Annu Rev Microbiol. 2008. 62:71-92.
  14. Wagner D, de With K, Huzly D, Hufert F, Weidmann M, Breisinger S, et al. Nosocomial acquisition of dengue. Emerg Infect Dis. 2004  10(10):1872-1873
  15. Engelthaler DM, Fink TM, Levy CE, Leslie MJ. The reemergence of Aedesaegypti in Arizona. Emerg Infect Dis. 1997 Apr-Jun. 3(2):241-242. 
  16. deMacedo FC, Nicol AF, Cooper LD, Yearsley M, Pires AR, Nuovo GJ. Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive    Diagn Mol Pathol. 2006 Dec. 15(4):223-228.
  17. Shah I. Dengue and liver disease.Scand J Infect Dis. 2008. 40(11-12):993-994.
  18. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg. 1992;47:265–270.
  19. Souza a LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis. 2004; 8(2): 156-163.

Corresponding Author

Dr Ranjit Kumar Nim

Lecturer, Dept of Medicine, UP UMS, Saifai, Etawah (Uttar Pradesh)